生命科学资讯

Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health

Roche's return to RNA continues with $1.7B deal for Sanegene program

Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative

China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug

Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again

Spring Health acquires Alma, expanding insurance reach in virtual mental health

3 major companies closing Massachusetts facilities; layoffs to affect about 250 workers - CBS News

Kyowa Kirin reveals side effect in trial; GSK was lone bidder for RAPT

FDA rejects Aquestive's allergy drug over packaging issues

Biggest gainers and losers for Jan. 26-30, 2026

FDA opens submissions for PreCheck program to speed up US factory builds

PacBio sells short-read DNA sequencing assets to Illumina for $48.1m - Investing.com

Illumina buys SomaLogic in bid to expand proteomics reach - The Pharma Letter

SanegeneBio licenses RNAi candidate to Genentech for $200M upfront

Pacific Biosciences of California Signs Asset Purchase Agreement With Illumina Cambridge - TradingView

Thermo Fisher Scientific’s venture arm brings Massey onboard - Global Venturing

Foundations Investment Advisors LLC Takes Position in 10x Genomics $TXG - MarketBeat

GSK walks away from pioneering Wave RNA editing drug

Thermo Fisher Scientific Inc. $TMO Stock Holdings Lessened by Arjuna Capital - MarketBeat

AI regulation lags despite entering higher-risk patient care